Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001615774-17-002760
Filing Date
2017-05-26
Accepted
2017-05-26 16:30:37
Documents
3

Document Format Files

Seq Description Document Type Size
1 S-3 s106322_s3.htm S-3 239790
2 EXHIBIT 5.1 s106322_ex5-1.htm EX-5.1 7651
3 EXHIBIT 23.1 s106322_ex23-1.htm EX-23.1 5268
  Complete submission text file 0001615774-17-002760.txt   253819
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: S-3 | Act: 33 | File No.: 333-218292 | Film No.: 17874379
SIC: 8731 Services-Commercial Physical & Biological Research